Literature DB >> 34257725

MicroRNA-148a-3p inhibits the proliferation of cervical cancer cells by regulating the expression levels of DNMT1 and UTF1.

Qing Chen1, Yidong Wang1, Huimin Dang2, Xiaoling Wu1.   

Abstract

MicroRNAs (miRs) serve a key role in carcinogenesis. miR-148a-3p has been demonstrated to act as a tumor suppressor in several tumors, such as epithelial ovarian cancer and esophageal cancer. However, to the best of our knowledge, the role of miR-148a-3p in cervical cancer remains unclear. In the present study, the expression levels of miR-148a-3p measured by reverse transcription-quantitative PCR were significantly decreased in cervical cancer tissues compared with that in normal cervical tissues. Furthermore, overexpression of miR-148a-3p markedly suppressed the proliferation of cervical cancer cells. The luciferase reporter assay demonstrated that DNA methyltransferase 1 (DNMT1) was the target gene of miR-148a-3p and that its expression measured by western blotting was inhibited by miR-148a-3p in cervical cancer cells. Correlation analysis highlighted that the expression levels of the undifferentiated embryonic cell transcription factor-1 (UTF1) were negatively associated with the expression levels of DNMT1 in cervical cancer tissues. Furthermore, DNMT1 knockdown increased the expression of UTF1 and decreased the methylation level of UTF1 promoter. These data demonstrated the expression levels of UTF1 were regulated by DNMT1 methylation in cervical cancer cells. Collectively, the results of the present study suggested that miR-148a-3p may inhibit the proliferation of cervical cancer cells by regulating the expression levels of DNMT1/UTF1, which provides potential therapeutic targets for cervical cancer.
Copyright © 2021, Spandidos Publications.

Entities:  

Keywords:  DNA methyltransferase 1; cell proliferation; cervical cancer; methylation; microRNA-148a-3p

Year:  2021        PMID: 34257725      PMCID: PMC8243077          DOI: 10.3892/ol.2021.12878

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells.

Authors:  A Okuda; A Fukushima; M Nishimoto; A Orimo; T Yamagishi; Y Nabeshima; M Kuro-o; Y i Nabeshima; K Boon; M Keaveney; H G Stunnenberg; M Muramatsu
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

3.  Conditional Knockdown of Endogenous MicroRNAs in CHO Cells Using TET-ON-SanDI Sponge Vectors.

Authors:  Alan Costello; Nga Lao; Martin Clynes; Niall Barron
Journal:  Methods Mol Biol       Date:  2017

4.  Long non-coding RNA miR143HG predicts good prognosis and inhibits tumor multiplication and metastasis by suppressing mitogen-activated protein kinase and Wnt signaling pathways in hepatocellular carcinoma.

Authors:  Xiong Lin; He Xiaoqin; Chen Jiayu; Fan Li; Li Yue; Xu Ximing
Journal:  Hepatol Res       Date:  2019-05-30       Impact factor: 4.288

5.  MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancer.

Authors:  Junbo Zuo; Jiazeng Xia; Feng Ju; Jiang Yan; Akao Zhu; Shimao Jin; Ting Shan; Hong Zhou
Journal:  Mol Cells       Date:  2013-03-29       Impact factor: 5.034

6.  MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer.

Authors:  H Zhang; Y Li; Q Huang; X Ren; H Hu; H Sheng; M Lai
Journal:  Cell Death Differ       Date:  2011-04-01       Impact factor: 15.828

Review 7.  Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.

Authors:  Francesca Fanini; Muller Fabbri
Journal:  Semin Cell Dev Biol       Date:  2016-12-09       Impact factor: 7.727

Review 8.  The Role of Mir-148a in Cancer.

Authors:  Yue Li; Xiyun Deng; Xiaomin Zeng; Xiaoning Peng
Journal:  J Cancer       Date:  2016-06-21       Impact factor: 4.207

9.  miR-148a inhibits cell proliferation and migration through targeting ErbB3 in colorectal cancer.

Authors:  Wei Zhao; Jianbao Zheng; Guangbing Wei; Kui Yang; Guanghui Wang; Xuejun Sun
Journal:  Oncol Lett       Date:  2019-07-05       Impact factor: 2.967

Review 10.  DNA methyltransferases: a novel target for prevention and therapy.

Authors:  Dharmalingam Subramaniam; Ravi Thombre; Animesh Dhar; Shrikant Anant
Journal:  Front Oncol       Date:  2014-05-01       Impact factor: 6.244

View more
  3 in total

1.  miR-148a promotes cell sensitivity through downregulating SOS2 in radiation-resistant non-small cell lung cancer cells.

Authors:  Yan Zhang; Xiaoqian Hu
Journal:  Oncol Lett       Date:  2022-02-24       Impact factor: 2.967

Review 2.  Human Milk Extracellular Vesicles: A Biological System with Clinical Implications.

Authors:  Somchai Chutipongtanate; Ardythe L Morrow; David S Newburg
Journal:  Cells       Date:  2022-07-30       Impact factor: 7.666

Review 3.  Role of Phosphatidylinositol 3-Kinase and Its Catalytic Unit PIK3CA in Cervical Cancer: A Mini-Review.

Authors:  Guojuan Sun; Qiang Zhang; Yi Liu; Ping Xie
Journal:  Appl Bionics Biomech       Date:  2022-08-21       Impact factor: 1.664

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.